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Abstract 
No uniform consensus has been established regarding post-pneumonectomy lung regeneration. This study was 
undertaken to determine whether airway-instilled lung- or bone marrow-derived cells are able to differentiate and 
reconstitute as lung component cells in the course of post-pneumonectomy lung growth. Bone marrow cells or lung 
cells obtained from C57 black (BL)/6-GFP mice were intratracheally instilled into C57BL/6 mice treated with left pneu-
monectomy and cell differentiation was examined. It is unclear whether intratracheally instilled lung or bone marrow 
cells differentiate into non-hematopoietic cells after pneumonectomy. However, regardless of whether pneumonec-
tomy is performed, intratracheally instilled bone marrow cells display a surface antigen profile that is similar to alveo-
lar macrophages. Furthermore, these newly differentiated macrophages function similarly to resident macrophages 
in terms of TNF-α production, suggesting that bone marrow stem cells acquire the same macrophage phenotype. In 
conclusion, intratracheally instilled bone marrow cells adapt to the surrounding microenvironment, directly differenti-
ating into alveolar macrophages, and remain in the alveolar space for at least 3 months.
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Background
Lung resection continues to be the primary treatment 
for lung cancer. One of the most important factors that 
determine the resectability level is the residual lung func-
tion. It is well known clinically that after lung resection 
in adults the residual lung increases in volume to some 
extent, but this is considered to be primarily due to 
hyperinflation, with minimal recovery (Laros and West-
ermann 1987). In children, recovery of lung function after 
lung resection has been reported (Nakajima et al. 1998). 
The fact that alveoli multiply after birth up until about 
8 years of age is well established (Kreisel et al. 2004). In 
addition, adult lungs transplanted into immature recipi-
ents have been reported to show hyperplastic growth 
(Binns et  al. 1997). These results taken together sug-
gest that restoration or augmentation of compensatory 
growth capability is possible, at least in part, even in the 
adult lungs.
Compensatory lung growth after lung resection has 
been reported in many animal models (Jancelewicz et al. 
2010; Takahashi et  al. 2011; Wada et  al. 2012; Fehren-
bach et al. 2008; Takahashi et al. 2010; Voswinckel et al. 
2004). It is well described as a phenomenon, yet little is 
known about its nature, extent or capacity for modula-
tion. Moreover, whether regeneration of new lung tissue 
is involved in the process of compensatory lung growth is 
at present controversial.
The objective of our study was to determine whether 
airway-instilled lung- or bone marrow-derived cells can 
differentiate and reconstitute lung component cells in 
post-pneumonectomy lung growth. To directly investi-
gate this, GFP-positive lung or bone marrow cells were 
instilled into the airway without isolating and condition-
ing the stem cells prior to instillation, and flow cytometry 
was performed to quantitate the fraction of the lung com-
ponent cells that was replaced by GFP-positive cells. Var-
ious kinds of cells are supposed to work together in lung 
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reconstitution, so the experimental step of stem cell iso-
lation might exclude or otherwise result in a malfunction 
of certain key stem cells. Thus, in order to maximize the 
chances of lung reconstitution, our method is the first, to 
the best of our knowledge, to skip any isolation and con-
ditioning of the stem cells before instilling them into the 
airways. We investigated the mechanism by which mes-
enchymal and bone marrow stem cells are in their naïve 
state involved in the reconstitution of the lung. In addi-
tion, we also examined whether intratracheally instilled 
bone marrow hematopoietic cells would adapt to the 
microenvironment in the airway and assume proper pat-
terns of differentiation. Moreover, the function and life 
span of these cells in the lung were also investigated.
Methods
Reagents
The reagents and materials used for this study were 
obtained from the following sources: dispase II was from 
Roche Applied Science (Indianapolis, IN, USA); fetal 
calf serum and collagenase type 1 were from Invitrogen 
(Carlsbad, CA, USA); phosphate buffered saline (PBS) 
and paraformaldehyde were from Wako (Osaka, Japan); 
deoxyribonuclease I from bovine pancreas and red blood 
cell lysing buffer were from Sigma-Aldrich (St. Louis, 
MO, USA); brefeldin A and permealization buffer were 
from eBioscience (San Diego, CA, USA) and 7-AAD 
solution and BD Fc Block were from BD Pharmingen 
(San Diego, CA, USA). The anti-mouse antibodies used 
for flow cytometry included the following: CD45 (clone: 
30-F11; eFluor 450), CD105 (clone: MJ7/18; PE), E-cad-
herin (clone: DECMA-1; eFluor 660), F4/80 (clone: BM8; 
eFluor 450), CD11c (clone: N418; PE), CD11b (clone: 
M1/70; PE-Cy7, eBioscience, San Diego, CA, USA); 
TNF-α (clone: MP6-XT22; PE-Cy7), VE-cadherin (clone: 
11D4.1; Alexa Fluor 647, BD Pharmingen, San Diego, 
CA, USA); Ep-CAM (clone: G8.8; PE), Ly6G (clone: 1A8; 
APC-Cy 7, BioLegend, San Diego, CA, USA). The anti-
mouse antibodies used for immunofluorescence included 
the following: GFP (ab290, AbCAM, Cambridge, MA, 
USA), F4/80 (AbD Serotec, Oxford, UK), and MOMA-2 
(AbD Serotec). Donkey anti-rat IgG and goat anti-rab-
bit IgG (Jackson ImmunoResearch Laboratories, West 
Grove, PA, USA) were used as secondary antibodies for 
double immunofluorescence staining.
Mice
Adult male C57BL/6 and transgenic mice expressing 
GFP, ubiquitously under control of the chicken b-actin 
promoter with the cytomegalovirus enhancer (C57BL/6-
Tg[CAG-EGFP]), were purchased from Japan SLC (Shi-
zuoka, Japan). The ages of the mice ranged from 6 to 
8  weeks. The mice were maintained in a full barrier 
facility until experimental use, and all of the experiments 
received institutional approval.
Experimental groups
According to the presence or absence of the GFP fluores-
cence of the intratracheally instilled lung or bone mar-
row cells and whether the recipient C57BL/6 mice were 
treated with left pneumonectomy, the mice were divided 
into experimental groups A, B and C. The recipient mice 
were randomly assigned to one of the three experimen-
tal groups. Group A consisted of C57BL/6 mice that 
were treated with left pneumonectomy and then received 
intratracheal instillation of lung cells or bone marrow 
cells obtained from wild-type mice. Group B consisted 
of untreated C57BL/6 mice that received intratracheal 
instillation of lung cells or bone marrow cells obtained 
from GFP mice. Group C consisted of C57BL/6 mice that 
were treated with left pneumonectomy and then received 
intratracheal instillation of lung cells or bone marrow 
cells obtained from GFP mice.
Pneumonectomy
In the pneumonectomy group, the mice were anesthe-
tized with 100 mg/kg of ketamine and 10 mg/kg of xyla-
zine administered subcutaneously. They were intubated 
with a 20-gauge catheter and connected to a rodent 
ventilator, adjusted to maintain a respiratory rate of 120 
breaths/min, a tidal volume of 10 mL/kg, 2-cm H2O-pos-
itive end-expiratory pressure, and 0.21 inspired oxygen. 
A 20-mm-long posterolateral skin incision was made, fol-
lowed by thoracotomy in the fifth intercostal space along 
with dissection of the serratus anterior and latissimus 
dorsi muscles. The left main bronchus with the left pul-
monary artery and vein were clipped at the hilum using 
a surgical stapler before removal of the lung. The whole 
left lung was resected from the pleural cavity. The tidal 
volume was reduced from 10 to 6  mL/kg after the lung 
was removed. The fifth intercostal space was closed with 
a single surgical suture, and the skin and muscle incisions 
were closed with two sutures to avoid excessive tension 
on the muscles. The duration of the mechanical ventila-
tion for the entire surgical procedure was approximately 
10  min. All of the mice recovered quickly after the ter-
mination of mechanical ventilation and were promptly 
extubated. The mice were observed daily for any signs of 
distress or changes in behavior.
Isolation of single lung cells for the airway instillation
The mice received an overdose of inhaled isoflurane and 
their pulmonary vasculature was perfused with PBS via 
the right ventricle. The PBS-perfused lungs were isolated, 
dispase II solution was infused into the lungs via the tra-
chea and the trachea was then ligated with silk suture. 
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After incubation for 45  min at 37  °C, the lungs were 
separated from the other mediastinal organs. Each lung 
was minced and digested in PBS with 0.1 % collagenase, 
0.01 % deoxiribonuclease I and 5 mM CaCl2 for 10 min 
(37  °C). Cells were suspended in red blood cell lysing 
buffer to remove red blood cells, washed once with PBS, 
centrifuged and suspended in PBS.
Isolation of bone marrow cells for the airway instillation
Bone marrow cells were collected from the femurs of the 
donor mice by aspiration and flushing, and were then fil-
tered through a 40-mm cell strainer (BD Biosciences, San 
Jose, CA, USA).
Intratracheal instillation
Intratracheal instillation was performed in the C57BL/6 
mice at 24  h after pneumonectomy and also in the 
untreated C57BL/6 mice. After inducing anesthe-
sia with ketamine and xylazine, the trachea was sur-
gically exposed, and a total volume of 50  μL of the 
lung or bone marrow cell suspensions was instilled 
via an angiocatheter through the trachea. In each 
recipient mouse, 2.03 ×  106 ±  0.08 ×  106 lung cells or 
4.35 × 106 ± 2.02 × 106 bone marrow cells were instilled 
respectively.
Isolation of single lung cells for flow cytometry
At 30  days after instillation, the mice received an over-
dose of inhaled isoflurane, and single lung cell suspen-
sions were prepared from the remaining lungs by a 
method similar to the one previously described. This 
digestion protocol does not result in the loss of the anti-
genicity of the hematopoietic, endothelial or epithelial 
cell markers used for flow cytometry.
Flow cytometry of single‑lung cell preparations
Single lung cells were suspended in 2 % fetal calf serum/
PBS. BD Fc Block was added to block Fc receptors, and 
after 5  min of incubation (4  °C), fluorochrome-conju-
gated antibodies were added to the cell suspension and 
incubated for 30 min (4 °C). The cells were then washed, 
counterstained with 7-AAD (BD Biosciences Pharmin-
gen), suspended in PBS and then analyzed using a Gallios 
flow cytometer (Beckman Coulter, Inc.).
Doublets were excluded through FSC-A/FSC-H. Data 
were collected by gating for 7-AAD-negative cells. Gates 
of interest for each fluorochrome were drawn using con-
trol antibodies of the same isotype. For each study, all of 
the specific antibodies were performed in all of the com-
binations to compensate for the overlapping fluorescence 
of one fluorochrome into the channel of others. Data 
were analyzed using the Flow Jo software (Treestar, San 
Carlos, CA, USA).
Bronchoalveolar lavage
Three months after the GFP-positive lung or bone mar-
row cells were intratracheally instilled into the untreated 
C57BL/6 mice, BAL was performed in the recipient mice. 
BAL cells were collected by lavaging the whole lungs with 
5.0 mL of PBS in 1.0 mL aliquots via tracheal cannula and 
slow withdrawal. The BAL cells were stained with fluo-
rochrome-conjugated antibodies and analyzed by flow 
cytometry.
Immunofluorescence
For immunofluorescence, the BAL cells were affixed to 
slides using cytospin. They were then fixed with 4 % para-
formaldehyde, and incubated in 5 % BSA and 0.1 % Triton 
X-100 to block nonspecific binding and permeabilize the 
cell membrane, respectively. The cells were then stained 
with primary and secondary antibodies according to 
standard procedures. Negative controls were performed 
with immunoglobulin G from the species from which the 
individual primary antibodies were obtained. Slides were 
mounted with Vectashield containing DAPI (Vector Lab-
oratories, Burlingame, CA, USA) and visualized under 
confocal microscopy (LSM710 ZEN, Zeiss). Stacks of 
images were obtained in the z-direction throughout the 
cells, and composite images were used for comparison.
Intracellular staining for TNF‑α
Three months after the GFP-positive bone marrow cells 
were intratracheally instilled into the untreated C57BL/6 
mice, BAL cells were obtained. Then these cells were 
incubated with or without 10  ng/ml LPS in medium 
(10  % FCS–RPMI 1640) containing brefeldin A (3.0  μg/
ml) for 2  h at 37  °C. Cells were centrifuged and resus-
pended with 2 % FCS–PBS. To prevent nonspecific bind-
ing of antibody to Fc receptors, cells were incubated with 
a rat anti-mouse CD16/CD32 antibody. Staining for the 
cell surface antigens Ly-6G and F4/80 was performed 
with fluorochrome-conjugated antibodies. Cells were 
washed and fixed with 2 % paraformaldehyde. Cells were 
washed again and suspended with permealization buffer. 
Cells were then incubated with a PE-Cy7-conjugated 
anti-TNF-α antibody or isotype control antibody. Cells 
were washed and resuspended for flow cytometric anal-
ysis. In this study, the macrophages were identified as 
F4/80+ Ly-6G− cells.
Results
Flow cytometric analysis of single‑lung cell suspensions
Single lung cells were isolated from the mice and sub-
jected to flow cytometric analysis for CD45, EpCAM 
and CD105/endoglin as specific markers for pan-leu-
kocytes, epithelial cells and endothelial cells, respec-
tively. According to the flow cytometric analysis results, 
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we classified lung component cells into hematopoi-
etic (CD45+ cells), epithelial (CD45−, EpCAM+ and 
CD105− cells), mesenchymal (CD45−, EpCAM− and 
CD105− cells) and endothelial cell fragments (CD45−, 
EpCAM− and CD105+ cells; Fig.  1). Most cells that 
expressed one endothelial cell marker (CD105 or VE-
cadherin) expressed both (Fig.  2a), and most cells that 
expressed one epithelial marker (EpCAM or E-cadherin) 
expressed both (Fig. 2b). Thus, each antibody was found 
to be endothelial- or epithelial-specific.
GFP expression in lungs subjected to lung cell instillation
The mice were divided into Groups A, B and C, as 
described in the “Methods” section. At 1  month after 
intratracheal instillation, single-lung cell suspensions 
were prepared from the mice and subjected to flow 
cytometric analysis for the presence or absence of GFP-
positive cells in the hematopoietic, epithelial, mesen-
chymal and endothelial cell fragments. Regardless of the 
(groups) group to which they belonged, no GFP-positive 
cell was detected in any of the epithelial, mesenchymal or 
endothelial cell fragments (Fig.  3). However, the hemat-
opoietic cell fragments contained GFP-positive cell pop-
ulations in groups B and C (Fig. 3).
GFP expression in the lungs subjected to bone marrow cell 
instillation
The method is quite similar to that described in “GFP 
expression in lungs subjected to lung cell instillation”, 
except that bone marrow cells were instilled into the 
airway instead of lung cells. The mice were divided into 
Group A, B and C, as described in the “Methods” section. 
No GFP-positive cell was detected in any of the epithelial, 
mesenchymal or endothelial cell fragments (Fig. 4). How-
ever, the hematopoietic cell fragments contained GFP-
positive cell populations in groups B and C (Fig. 4).
Identification of GFP‑positive cells by surface antigens
Because the intratracheally instilled GFP-positive lung 
cells were positive for CD45 in the single-lung cell sus-
pensions and did not differentiate into any other lung 
component cell, the instilled cells were speculated to 
Fig. 1 Protocol of the flow cytometric analysis. Single lung cells were obtained from the mice and analyzed by flow cytometry. Most of the single 
lung cells, distributed according to their values of forward and side scatter, were gated at the initial window (the upper left panel). Next, doublets 
and dead cells were excluded by FSC-A/FSC-W and 7-AAD staining, respectively (the upper middle and upper right panels). The expression of the 
pan-leukocyte marker CD45 designated a hematopoietic fragment (fragment I). CD45-negative cells were further subjected to flow cytometric 
analysis for the expression of the endothelial cell marker CD105 and epithelial marker EpCAM. The cells were divided into the following fragments: 
the EpCAM+ CD105− fragment (fragment II: epithelial cells), EpCAM− CD105− fragment (fragment III: mesenchymal cells) and EpCAM− CD105+ 
fragment (fragment IV: endothelial cells). We classified single lung cells into the fragments I to IV according to this protocol and analyzed the cells 
for the presence or absence of GFP fluorescence in each fragment in subsequent experiments
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reside in the airway. At 3  months after intratracheal 
instillation, the recipient mice were sacrificed and BAL 
cells collected. Flow cytometric analysis of surface anti-
gen expression in the BAL cells was performed to iden-
tify GFP-positive cells. When live cells were gated, 
the BAL fluid cells were classified as GFP-positive or 
GFP-negative cells (Fig.  5a). Both the GFP-positive and 
GFP-negative cells were F4/80+, Ly6G−, CD11c+ and 
weakly CD11b+, while the GFP-positive cells exhibited a 
staining pattern identical to that of the residential mac-
rophages in the GFP-negative cells (Fig. 5a, b).
Next the mice that were intratracheally instilled with 
GFP bone marrow cells were also examined in a similar 
manner. Both the GFP-positive and GFP-negative cells in 
the BAL fluid cells were F4/80+, Ly6G−, CD11c+ and 
weakly CD11b+, while the GFP-positive cells exhibited a 
staining pattern identical to that of the GFP-negative cells 
(Fig. 6a, b). Furthermore, the flow cytometric analysis of 
the bone marrow cells derived from GFP mice revealed 
that the staining patterns of CD11c, CD11b, Ly6G and 
F4/80 markedly differed from those of the GFP-positive 
cells collected by BAL (Fig. 6c).
Immunofluorescence of airway‑instilled bone marrow cells
When BAL cells were collected and examined under 
confocal microscopy at 3 months after the intratracheal 
instillation of GFP-positive bone marrow cells, the GFP-
positive cells expressed F4/80 and MOMA-2, which are 
Fig. 2 Specificity of the endothelial and epithelial markers. Single lung cells were analyzed for the endothelial markers CD105 and VE-cadherin 
as well as the epithelial markers EpCAM and E-cadherin. a Most cells that expressed one endothelial marker expressed both (n = 3, with similar 
results). b Most cells that expressed one epithelial marker also expressed both (n = 3, with similar results)
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markers of mature macrophages, as in the case of the 
GFP-negative residential macrophages (Fig. 7).
TNF‑α production in airway‑instilled bone marrow cells
In the absence of LPS treatment, TNF-α was hardly 
expressed in either GFP positive or negative cells 
(Fig.  8). After 2  h of LPS treatment, intracellular stain-
ing of TNF-α exhibited an evidently higher expression 
in both GFP positive and negative cells compared to 
LPS-untreated cells. There were no differences in TNF-α 
expression between GFP positive and negative cells irre-
spective of the presence or absence of LPS treatment.
Fig. 3 Expression of GFP in the lung subjected to intratracheal instillation of GFP-expressing lung cells. Lung single-cell digests were obtained from 
the recipient mice at 1 month after instillation of the lung cell suspensions. Group A was the negative control for GFP fluorescence. Regardless of 
the group to which they belonged, no GFP-positive cell was detected in any of the epithelial, mesenchymal and endothelial cell fragments. How-
ever, the hematopoietic cell fragments contained GFP-positive cell populations in groups B and C. The experiment was repeated 3 times (n = 3), 
yielding similar results
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Discussion
The intratracheally instilled bone marrow cells did not 
differentiate into non-hematopoietic cells in the lung. 
This is consistent with the conventional concept that 
transdifferentiation is unlikely to occur beyond the 
germ layer (Nicol-Benoit et al. 2013; Terada et al. 2002; 
Ying et al. 2002). However, bone marrow cells exhibited 
similar patterns of surface antigens and similar func-
tion of TNF-α production in response to LPS treatment, 
with residential macrophages, suggesting hematopoietic 
Fig. 4 Expression of GFP in the lung subjected to intratracheal instillation of GFP-expressing bone marrow cells. Lung single-cell digests were 
obtained from the recipient mice at 1 month after instillation of the bone marrow cell suspensions. Group A was the negative control for GFP fluo-
rescence. No GFP-positive cell was detected in any of the epithelial, mesenchymal or endothelial cell fragments. However, the hematopoietic cell 
fragments contained GFP-positive cell populations in groups B and C. The experiment was repeated 3 times (n = 3), yielding similar results
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stem cells progressed to the alveolar macrophage phe-
notype. In general, the process of differentiation into 
alveolar macrophages consists of two stages. (van 
Furth et  al. 1972). Hematopoietic stem cells in the 
bone marrow first differentiate into monocytes, which 
are released into blood; then, the monocytes are trans-
ported through the interstitial tissue into the pulmonary 
alveoli, where the monocytes further differentiate into 
alveolar macrophages. To the best of our knowledge this 
is the first demonstration that bone marrow stem cells 
are able to adapt to the surrounding microenvironment 
and differentiate into alveolar macrophages in a single 
stage.
In terms of the limitations of this study, macrophages 
in the bone marrow may have proliferated in the alveoli. 
However, another analysis did not reveal any significant 
difference between the GFP-positive and GFP-negative 
macrophages in ki-67 staining at 1, 3, and 5 weeks after 
instillation (unpublished data). Thus, rapid proliferation 
after intratracheal instillation was unlikely for the small 
number of macrophages that were present in the bone 
marrow.
Much remains unknown about the differentiation 
and generation of alveolar macrophages, as well as the 
trigger for differentiation from monocytes into mac-
rophages. Many basic studies have been conducted in 
the following manner: hematopoietic stem cells are col-
lected and ex vivo cultured with various inducers of dif-
ferentiation to observe morphological or phenotypic 
changes (Gupta et al. 2014; Huang et al. 2010; Lutz et al. 
1999; Wang et  al. 2014). Our findings in the present 
study enabled direct in vivo analysis of the induction of 
differentiation into macrophages. The in vivo generation 
of macrophages from hematopoietic precursors in large 
quantities will prove critical to the investigation of their 
biology.
This study shows that alveolar macrophages could 
be induced to incrementally proliferate in  vivo for a 
long period. In the future, this finding may be clinically 
applied to achieve antitumor effects on lung malignancy 
Fig. 5 Identification of GFP-positive cells in the lung subjected to intratracheal instillation of GFP-expressing lung cells. At 3 months after intratra-
cheal instillation of the lung component cells, bronchoalveolar lavage was performed in the recipient mice, and flow cytometric analysis of the 
surface antigens was performed on the BAL cells. a After the exclusion of doublets and dead cells, the BAL fluid cells were classified as GFP-positive 
cells (group I) or GFP-negative cells (group II). The cells in group II are assumed to be host-specific residential macrophages that were originally 
present in the pulmonary alveoli. Groups I and II were F4/80+, Ly6G−, CD11c+, and weakly CD11b+. b The histogram shows that the expression 
patterns of F4/80, Ly6G, CD11c, and CD11b were identical in groups I and II. The red lines indicate the isotype control; the blue lines, GFP-negative 
cells; and the yellow lines, GFP-positive cells. The experiment was repeated 3 times (n = 3), yielding similar results
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or preventive effects on lung infection. Basic studies on 
lung cancer treatment or pneumonia prevention using 
animal models are awaited.
Conclusions
In conclusion, we suggest that intratracheally instilled 
lung or bone marrow cells might not differentiate into 
Fig. 6 Identification of GFP-positive cells in the lung subjected to intratracheal instillation of GFP-expressing bone marrow cells. At 3 months after 
the intratracheal instillation of the bone marrow cells, bronchoalveolar lavage (BAL) was performed in the recipient mice, and flow cytometric analy-
sis of surface antigens was performed on BAL cells. a The BAL fluid cells were classified as GFP-positive cells (group I) or GFP-negative cells (group 
II). Both GFP-positive BAL cells (group I) and GFP-negative BAL cells (group II) were F4/80+, Ly6G−, CD11c+, and weakly CD11b+. b The histogram 
shows that the expression patterns of F4/80, Ly6G, CD11c, and CD11b were identical in groups I and II. The red lines indicate the isotype control; 
the blue lines, the GFP-negative cells; and the yellow lines, GFP-positive cells (n = 3, with similar results). c The flow cytometric analysis of the bone 
marrow cells derived from the GFP mice revealed the staining patterns of CD11c, CD11b, Ly6g and F4/80 to be markedly different from those of the 
GFP-positive cells in the BAL cells. The red lines indicate the isotype control (n = 3, with similar results)
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non-hematopoietic cells after pneumonectomy. Mean-
while, regardless of whether pneumonectomy is per-
formed, intratracheally instilled bone marrow cells do 
adapt to the surrounding microenvironment, directly dif-
ferentiating into alveolar macrophages and remaining in 
the alveolar space for at least 3 months.
Fig. 7 Immunofluorescence of GFP-positive cells in the airway. When BAL cells were collected and examined under confocal microscopy at 
3 months after intratracheal instillation of GFP-positive bone marrow cells, the GFP-positive cells expressed both F4/80 and MOMA-2, as was also 
the case for the GFP-negative residential macrophages. The experiment was repeated 3 times (n = 3), yielding similar results. Typical images are 
shown
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